Articles on Biopiracy

Displaying all articles

The Rapa Nui people are mostly invisible in the origin story of rapamycin. Posnov/Moment via Getty Images

A billion‑dollar drug was found in Easter Island soil – what scientists and companies owe the Indigenous people they studied

Cancer. Diabetes. Aging itself. Rapamycin’s potential to treat an array of diseases has been a source of scientific fascination. But many aren’t aware of its origins – and its complicated legacy.
Small scale farmers aren’t getting much from the rooibos tea access and benefit sharing agreements. Paul Weinberg

South Africa’s small‑scale rooibos tea growers aren’t getting much from an industry deal – why it’s not fair

Rooibos herbal tea was first farmed by Indigenous South Africans who were forced off their land during apartheid.
The blood of rare horseshoe crabs is sometimes used in the development of vaccines. Sinhyu Photographer/Shutterstock

How profits from big pharma’s use of genetic information could revolutionise nature conservation

The genetic codes of plants and animals are stored in global databases, often without proper compensation to the countries where they originated. A potential solution will be discussed at Cop16.
Traditional medicines sold at a South African market. Rebecca and William Beinart

The story of the pharma giant and the African yam

In the 1950s, the African yam was exploited by drugs firm Boots to produce cortisone. But South Africans fought back against the plundering of a plant that they used for traditional healing.
Will synthetic rhino horns decrease demand or aid law enforcement? David W Cerny/Reuters

The trouble with using synthetic rhino horn to stop poaching

A company plans to flood the market with synthetic rhinoceros horn in an effort to slow poaching but these types of commercially driven conservation efforts are fraught with problems.

Top contributors

More